ISRG
Intuitive Surgical Inc
$468.52-2.82%
Setup
①BreakoutBreakout
Buy Zone
$440.4-$462.42
Sector
Medical Instruments & Supplies
Industry
Medical Instruments & Supplies
31
Recommendation
Avoid
Avoid①
Breakout fired, but quality 31 (RS-based) < 70 — weak leadership, not a CAN-SLIM buy
ISRG chart
Loading chart…
ADX
Weak or Absent19.4Long Term
Down ↓Intermediate Term
Down ↓Short Term
Down ↓Overall Quality31
RS Rating
19
relative strength
Fundamentals
59
Weak fund-Q
Volume Demand
68
+93% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Medical Instruments & Supplies
Trade Plan
Avoid
Entry
$440.4
Entry Zone
$440.4-$462.42
Stop / Risk
$405.17
RS Rating
19
Volume confirmed
No
Targets
$528.48 / $550.5
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $440.4–$462.42Stop $405.17Target $528.48 / $550.5
Market regimeRange
Quality31
RS Rating19
Above 50-MA+14.77%
Above 200-MA+8.56%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
31
MarketRange
Setup①BreakoutBreakout
ConfidenceMedium · 476 trades · 38% win · +0.30R
Fund-Q59 · Weak
StatusAvoid①
Stock Data
52-Week Range329 – 604
Price % Chg YTD-17.28%
Price % Chg 4wk13.03%
50-Day Avg Vol2.4 Mil
P/E Ratio52.3
Market Cap$150B
SectorHealthcare
IndustryMedical Instruments & Supplies
Company Fundamentals
EPS % Chg (Qtr)-23.63%
Sales % Chg (Qtr)21.7%
EPS Growth 5y21.79%
Sales Growth 5y18.22%
Annual ROE17.97%
Gross Margin67.17%
Operating Margin32.25%
Net Margin25.54%
Debt / Equity0.00
Setup levels
Current price
$468.52
Pivot
$440.4
Distance to buy
-22.4%
52-week range
328.58-603.92
Trigger evidence
W double-bottom base
broke the middle peak 440.4 on volume ≥1.4×
Pattern levels: pivot 440.4
Financial health checks
4/5
Return on equity above 15%
ROE 17.97%
Net margin above 10%
Net margin 25.54%
EPS growing quarter on quarter
EPS q/q -23.63%
Sales growing quarter on quarter
Sales q/q 21.7%
Debt to equity below 1.0
D/E 0.00
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE17.97%
vs sector -4.6%
Net margin25.54%
vs sector +7.9%
Gross margin67.17%
vs sector +0.0%
EPS growth q/q-23.63%
vs sector -31.2%
Sales growth q/q21.7%
vs sector +3.0%
Debt / equity0.00
vs sector -0.65
Business quality
59
GradeWeak
EPS rating24
P/E52.3
Market cap$150B
IndustryMedical Instruments & Supplies
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-04
Trigger date
—
Days on list
2
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.